HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.

AbstractOBJECTIVES:
To investigate the roles of glutathione and glutathione-S-transferase (GST) in cisplatin-resistance mechanisms in human bladder cancer, by using glutathione-depleting or GST-blocking agents.
MATERIALS AND METHODS:
Cisplatin-resistant human bladder cancer cell lines were established by continuous exposure of T24 cells to increasing concentrations of cisplatin. Buthionine sulphoximine (BSO), ethacrynic acid and indomethacin were used to deplete glutathione or block GST. Intracellular glutathione content, GST activity and cisplatin cytotoxicity were determined after exposing parental and drug-resistant cell lines to these agents.
RESULTS:
Intracellular glutathione content and GST activity were significantly decreased, and cisplatin cytotoxicity significantly enhanced, in both parental and resistant cell lines by glutathione-depleting or GST-blocking agents. However, the resistance of cisplatin-resistant cell lines did not fully recover to that of the parental cells with combined BSO and indomethacin.
CONCLUSIONS:
Both increased glutathione content and GST activity are significant in the cisplatin resistance of human bladder tumour cells. Because BSO, ethacrynic acid and indomethacin caused a partial recovery of resistance in the cisplatin-resistant cell line, further studies are needed to investigate their efficacy for treating patients with metastatic bladder carcinoma resistant to cisplatin.
AuthorsSeok-Soo Byun, Soo W Kim, Hwang Choi, Chongwook Lee, Eunsik Lee
JournalBJU international (BJU Int) Vol. 95 Issue 7 Pg. 1086-90 (May 2005) ISSN: 1464-4096 [Print] England
PMID15839938 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Glutathione Transferase
  • Glutathione
  • Cisplatin
Topics
  • Antineoplastic Agents (therapeutic use)
  • Cisplatin (therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Resistance, Neoplasm
  • Enzyme Inhibitors (pharmacology)
  • Glutathione (antagonists & inhibitors)
  • Glutathione Transferase (antagonists & inhibitors)
  • Humans
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms (drug therapy, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: